title: Emerging treatments for Tourette's disorder.
abstract: Tourette's disorder is a childhood-onset neuropsychiatric disorder characterized by multiple motor and vocal tics. Many children with Tourette's disorder improve throughout adolescence. However, some adults with Tourette's disorder still experience severe symptoms and significant disability. This article examines the evidence base for current treatments for Tourette's disorder. Emerging treatments such as deep brain stimulation, habit reversal therapy, and repetitive trans-cranial magnetic stimulation are also discussed.
authors.affiliation: Yale Child Study Center, 230 South Frontage Road, New Haven, CT 06520, USA. Michael.bloch@yale.edu
authors.forename: Michael H
authors.initials: MH
authors.lastname: Bloch
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000627:therapeutic use; D046690:Deep Brain Stimulation / Q000379:methods; D004185:Disability Evaluation; D004358:Drug Therapy / Q000379:methods; D004565:Electroconvulsive Therapy / Q000379:methods; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000453:epidemiology / Q000523:psychology; D005879:Tourette Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D050781:Transcranial Magnetic Stimulation
chemical_list: D000316:Adrenergic alpha-Agonists; D014150:Antipsychotic Agents; D001905:Botulinum Toxins